Dimitri BEDO (@DimitriBedo) header
Dimitri BEDO (@DimitriBedo) profile picture

Interne en Nephrologie-Dialyse-Transplantation au CHU de Strasbourg, intérêt pour la recherche en médecine cardio-rénale et la transplantation rénale.

Strasbourg, France
Joined July 2021
Photo by Dimitri BEDO (@DimitriBedo)Photo by Dimitri BEDO (@DimitriBedo)Photo by Dimitri BEDO (@DimitriBedo)Photo by Dimitri BEDO (@DimitriBedo)
Dimitri BEDO retweeted
Arteriovenous fistula for haemodialysis as a predictor of de novo heart failure in kidney transplant recipients doi.org/10.1093/ckj/sfae105
14
44
2,269
Dimitri BEDO retweeted
#ACC25 #CircSimPub In a prespecified analysis of the SOUL trial, oral semaglutide reduced MACE outcomes independently of concomitant SGLT2i use in patients with T2DM and ASCVD and/or CKD. GLP1-RA and SGLT2i can be saf... ahajrnls.org/41RZkDd #AHAJournals @Dr_Birkenfeld @RBusui
18
2
41
5,861
Dimitri BEDO retweeted
Early and Sensitive Detection of #Cisplatin Induced #KidneyInjury Using Novel #Biomarkers #VisualAbstract by @jmteakell kireports.org/article/S2468-…
1
13
18
2,175
Le SNIN tient à vous souhaiter une belle et heureuse année 2025 🥳 On en profite pour vous présenter le bureau 2024/2025 ✨ (un peu tardivement, mais mieux vaut tard que jamais !!) Le meilleur reste à venir ! 🫡
1
8
925
Équipe très sympathique et compétente !!!
67
Now online in @NDTsocial Tissue fibrosis in cardiorenal syndrome: crosstalk between heart and kidneys 🧐 The repair process in cardiorenal injury involves a regenerative phase characterized by proliferation and polyploidization. ▶️academic.oup.com/ndt/article…
21
1
44
4,144
LAURÉATS 2024] 🏅Félicitations à @RaphaelCarapito, lauréat du prix Éloi Collery pour ses travaux sur la #pathologie #alloimmunes et #autoimmunes/#inflammatoires @CHRUStrasbourg @inserm 🛜 bit.ly/3ZYIAZG
1
3
2
334
Un grand big-up et toutes mes félicitations au meilleur des nephrovirologues!
[LAURÉATS 2024] 🏅Félicitations à @ilies_benotmane, lauréat du prix Drieu-Cholet pour ses travaux sur la #transplantation #rénale #Covid" @CHRUStrasbourg @SFTJuniors @Inserm 🛜 bit.ly/3ZYIAZG
1
97
Type 2 myocardial infarction: challenges in diagnosis and treatment. Read this State-of-the-Art Review just published in #EHJ 👉 bit.ly/3VBGdd4 @RoccoMontone @ehj_ed
1
53
2
134
14,403
Dimitri BEDO retweeted
Atrial fibrillation (AF) is associated with increased rates of stroke, heart failure, and mortality. This narrative review examines the epidemiology, pathophysiology, diagnosis, and treatment of AF. ja.ma/3ZDdZ2D
6
189
9
649
93,613
Dimitri BEDO retweeted
🧐Selected from our joint @ERAkidney and @escardio Cardio-Kidney Collection: academic.oup.com/ndt/pages/j… ➡️Proximal versus distal diuretics in congestive heart failure 🔓doi.org/10.1093/ndt/gfae058
18
51
3,345
Dimitri BEDO retweeted
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis 🆓doi.org/10.1093/ndt/gfae106
1
26
3
56
4,970
Dimitri BEDO retweeted
Changing treatment paradigms for membranous nephropathies 🆓doi.org/10.1093/ndt/gfae141
1
58
3
130
10,667
Risque bien de changer les pratiques !
Original Article: Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma (AQUILA) nej.md/3Zh3pOJ #ASH24 | @ASH_hematology
72
Dimitri BEDO retweeted
Original Article: Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease (EPIC-CAD) nej.md/3Z1D1d3 Editorial: Atrial Fibrillation and Stable Coronary Artery Disease nej.md/3T5MV9G #Cardiology
23
1
48
15,055
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes: @NEJM 🥸 Day 3 of #AHA24 continues: Great work @AHAScience 😱 Let's summarize BPROAD trial 👇👇👇
3
101
2
369
60,813
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: @NEJM 🥸The SUMMIT trial - @AHAScience 😱 Summary 👇👇👇
16
142
5
728
118,389
Dimitri BEDO retweeted
In the CLEAR randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years. Full trial results: nej.md/4i2U6dV
1
57
4
148
49,607
Dimitri BEDO retweeted
Presented at #ACR24: In the MITIGATE involving 135 participants with IgG4-related disease, inebilizumab was associated with significantly lower flare risk and greater likelihood of complete remission than placebo at 1 year. Full trial results: nej.md/4euxr6Y
15
1
34
14,240